Showing posts with label cancerous tumors. Show all posts
Showing posts with label cancerous tumors. Show all posts

Monday, May 18, 2009

Orally Administered Beta-Glucan May Prevent Cancer


A new study showed that immune suggestion has an important effect on tumor growth in the animal copies. Secure and effective forms of the immune suggestion can zellulare immunity increase, which increases in sequence the activities of the T-aides cells and the natural murderer cells.

Betaglukan was pointed to the increase activation of the macro phages, the Lymphozyteproduktion and the activity of the natural murderer cell. Some studies have that Betaglukan level of IL-1 can also increase, and TNF alpha indicated, which is instrumental in the Immunsystemkorrdination, and which bodies help can to eliminate tumors more efficiently.

The use of the Betaglukans is from the special interest to the cancer patient, which chemotherapy and/or radiotherapy undergo. This is because of the fact that Betaglukane showed an amazing ability to accelerate resumption in illuminated animal copies even if it after the radiation dosage is given. It knows resumption of the marrow after chemotherapy, something, those for the restriction of tumor growth is vital and prevention of the sticking on complications also stimulates during the treatment.

Although more controlled attempt shows the data, which are made available in this study, are still rather premature and with a larger be confirmed must, it the effectiveness and the potential of the Betaglukans than treatment for cancer-like tumors.


glucan, beta, treatment, immune, shown, killer, natural, cells, increase, chemotherapy, natural killer cells, natural killer cell, beta glucan, killer cell activity, animal specimens, cellular immunity, cancerous tumors, system coordination, beta glucans, helper cells, tnf alpha, radiation dose, radiation treatment, immune stimulation, infectious complications, cancer patient, tumor growth, controlled trial, macrophages, bone marrow

Wednesday, April 8, 2009

Sarcomatoid Mesothelioma: A Deadly Curse Of Asbestos


Sarcomatoid Mesotheliom is a rather rare kind of cancer caused because of the asbestos exposure. While it is difficult to determine Sarcomatoid Mesotheliom it hardly reacts in any kind therapy. This is all diseases standing asbestos in connection the most serious. The possibility of finding this kind of cancer is on the lips and the larynx. However in certain cases it can affect the oral cavity in addition. Like all further forms of Mesotheliomkrebsen, this cancer is reacted hardly a deadly illness and on each possible working method. Although radiotherapy for the treatment of these cancer-like tumors is recommended, but, some of them be not radiation-sensitive and can radiation for treatment can provoke.

Diagnosis of the Sarcomatoid Mesothelioms:

The distinction sarcomatoid of the Mesothelioms of other cell tumors by light microscopy is rather difficult. The role of immunohistochemistry is not well defined also in its diagnosis. Since sarcomatoid Mesotheliom is not always cytokeratin negative, the distinction between it and Sarkom is not always possible. In this connection the doctors took up themselves a study, in order to investigate the utility program of Diagnoseimmunohistochemistry for differentiating sarcomatoid the Mesothelioms of its histological imitators, of high-quality Sarkom and of sarcomatoid cancer of the lungs ulcer.

For his study the researchers stained the Mesotheliome with sarcomatoid components. They determined the intensity and the distribution of staining assistance of a half quantitative scale. Only tumors with unmistakable staining were considered as positive for scheduling. Then they compared the immune OF of profiles of these tumors with 24 high-quality Sarkomen. Sarcomatoid the cancer ulcers were stained also for thyroid transmission factor-1 (TTF-1).

The study showed the fact that Cytokeratin 5/6 stained most epithelioids was stained rarely but sarcomatoids. On the one hand Calretinin stained and thrombomodulin each 70% of sarcomatoid. All 10 sarcomatoids was negative for TTF-1. This led to the summary that broad immune OF exists a covering under different sarcomatoids. Cytokeratin and calretinin have most value, if they differentiate between different sarcomatoids. Clinical-pathological data, particularly information over the rough appearance of the tumor are rather important for sarcomatoid tumors. So it should be noticed with the microscopic and immunohistochemical discoveries and referred carefully one on the other.


sarcomatoid, mesothelioma, tumors, stained, sarcomatoids, study, cytokeratin, treatment, quite, cancer, diagnostic immunohistochemistry, asbestos related diseases, cancerous tumors, light microscopy, cell tumors, asbestos exposure, oral cavity, calretinin, sarcomatoid carcinoma, uncommon type, type of cancer, transcription factor, radiation therapy, carcinomas, larynx, mesothelioma, ttf, carcinoma, tabulation, differentiation